Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2

Updated and revised versions of COVID-19 vaccines are vital due to genetic variations of the SARS-CoV-2 spike antigen. Furthermore, vaccines that are safe, cost-effective, and logistic-friendly are critically needed for global equity, especially for middle- to low-income countries. Recombinant prote...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccines (Basel)
Autors principals: Seephetdee, Chotiwat, Buasri, Nattawut, Bhukhai, Kanit, Srisanga, Kitima, Manopwisedjaroen, Suwimon, Lertjintanakit, Sarat, Phueakphud, Nut, Pakiranay, Chatbenja, Kangwanrangsan, Niwat, Srichatrapimuk, Sirawat, Kirdlarp, Suppachok, Sungkanuparph, Somnuek, Chutipongtanate, Somchai, Thitithanyanont, Arunee, Hongeng, Suradej, Wongtrakoongate, Patompon
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8151071/
https://ncbi.nlm.nih.gov/pubmed/34066016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9050498
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars